As an important regulator of oncogenic signaling, FLOT2 participates in the development of cancer via PI3K/AKT/MAPK, PI3K/AKT/mTOR, PI3K/AKT/FOXO and NF-κB signaling pathways. This evidence concerns the gene MTOR and cancer.